Skip to content
healthcare.dev

Alhemo

NDC 0169-2084, concizumab, injection, solution, from Novo Nordisk.

Product NDC
0169-2084
Status
Listed
Labeler
Novo Nordisk
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761315
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0169-2084 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CONCIZUMAB40 mg/mL

Pharmacologic classes

Tissue Factor Pathway Inhibitor Antagonist [EPC]; Tissue Factor Pathway Inhibitor Antagonists [MoA]

Package NDCNDC-11Package
0169-2084-15001692084151 SYRINGE, PLASTIC in 1 CARTON (0169-2084-15) / 1.5 mL in 1 SYRINGE, PLASTIC

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/156f6404-1f6f-417f-bcf8-f07a27a82cc1
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0169-2084

Use it

Look up 0169-2084 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0169-2084 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0169-2084. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.